The FDA and CDC issued warnings to consumers about the potential risks of the cannabinoid thco flower delta-8 THC, a compound that has grown in popularity but is still in an especially grey regulatory area.
There is a lack of rules governing delta-8 THC, the most commonly known and naturally occurring cannabinoid, which can be synthesised using cannabis from legal hemp.
The FDA and CDC are aware of the growing availability and demand for delta-8, which is being sold in states regardless of whether they have legalized marijuana. The agencies say they are seeing more adverse health effects from people using it.
Consumers may be at risk due to unclear and incomplete labeling of cannabis products. The CDC Injury Center has more information on this.
The FDA said it’s important for consumers to know that the products have not been evaluated or approved for safe use. They should be kept out of reach of children and pets and marketed in ways that put the public health at risk.
Some delta-8 products are being labeled as “hemp”, which could confuse consumers who are looking for non-intoxicating cannabinoids. According to the FDA, it has received 22 adverse events reports from people who have experience symptoms such as vomiting, hallucinations, trouble standing, and loss of consciousness.
The FDA is concerned that consumers may be exposed to much higher levels of the substance than are naturally occurring inHemp cannabis raw extracts. Historical use of cannabis cannot be relied upon to establish a level of safety for these products.
There are potential health risks associated with products containing the psychoactive substance.
There are concerns that the process of synthesising delta-8thc from cannabidiol could lead to contaminated products.
The availability of psychoactive cannabis products in states where non-medical adult cannabis use is not permitted has increased because of the rise in delta-8 THC products in the marijuana and hemp marketplaces. Changes in product content, manufacturing practices, labeling, and misunderstanding of the psychoactive properties of delta-8 THC may lead to unforeseen effects among consumers.
Neither agency proposed banning the production or sale of cannabinoid. Retailers should give information to consumers about the psychoactive qualities of delta-8 THC, according to the CDC.
It said that retailers selling cannabis products should report total THC content on product labeling.
State lawmakers and regulators are aware of the increased consumer interest in delta-8 products and have taken various steps to either prohibit or ban it. In Kentucky, the state agriculture department banned the distribution of delta-8 THC, while Michigan put its Marijuana Regulatory Agency in control of the product and set an age limit of 21 for its use
Marijuana policy conflicts have left gaps in access to traditional cannabis products, which is why the rise of delta-8 THC is a result.
Some agencies have concerns about the unregulated nature of these products. He said that the artificial market demand for these products is a result of marijuana prohibition. Consumers would have little to no interest in experimenting with these unregulated imitations if they were legal. Unlicensed producers and distributers are happy to fill the void without regulated access to cannabis.
Photo by Kimzy Nanney.